Sorry, this page is not found.

Subscriber

Bright Minds Biosciences

Toronto, Canada

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Ask Bright Minds Biosciences

Visits

Questions

Answers

Best Answers

Points

Groups

Group Posts

Posts

Comments

Followers

Members

Menu